Wound Care Medicare Advantage Billing: Prior Auth, Reimbursement, and Plan Differences

Wound Care Medicare Advantage Billing

More than half of all Medicare beneficiaries are now enrolled in Medicare Advantage plans. As of 2025, MA penetration sits at roughly 54% nationally, and in many wound care markets -- particularly in the Southeast, Texas, and Florida -- that number is closer to 60% or higher. If you run a wound care practice and you are not actively managing your MA payer relationships, you are leaving the majority of your Medicare revenue subject to rules you may not fully understand.

Medicare Advantage is not traditional Medicare with a different card. MA plans are private insurers administering Medicare benefits under contract with CMS. They can -- and do -- layer their own prior authorization requirements, reimbursement schedules, and coverage criteria on top of Medicare's national and local coverage policies. For wound care, that distinction creates real operational and financial consequences that affect every claim you submit.

MA vs FFS: The Fundamental Differences for Wound Care

Understanding the structural differences between Medicare Fee-for-Service and Medicare Advantage is the foundation of billing correctly for both.

Payment Flow

Medicare FFS pays claims based on the Medicare Physician Fee Schedule. You submit a claim, it meets LCD criteria, and Medicare pays the fee schedule amount minus the patient's coinsurance. The rate is the rate -- no contract negotiation, no network restrictions.

Medicare Advantage pays based on the contract your practice negotiated with the specific MA plan. That contract sets your reimbursement rates, network participation terms, and which services require prior authorization. Out-of-network reimbursement is lower and the administrative burden is significantly higher.

Coverage Determination

Medicare FFS coverage is governed by National Coverage Determinations and Local Coverage Determinations issued by your MAC. If a service meets the LCD criteria, it is covered.

Medicare Advantage plans must cover at minimum everything original Medicare covers. But they can layer utilization management controls -- prior authorization, step therapy requirements, preferred provider restrictions -- that original Medicare does not impose. A service that Medicare FFS covers without pre-service review may require a full PA package under the patient's MA plan.

Administrative Burden

Billing the same debridement or skin substitute application to an MA plan takes more work than billing Medicare FFS. You verify coverage, check PA requirements, submit the PA if required, wait for approval, treat, and then submit the claim. For FFS, you verify coverage, treat, and submit. That difference multiplies across every MA patient.

Prior Authorization: The MA Operational Tax

Prior authorization is the single largest operational difference between MA and FFS billing for wound care. If you have not already, read the full prior authorization guide for workflow details. Here is how PA requirements break down by treatment category under MA plans.

Skin Substitutes and CTPs

Nearly every MA plan requires prior authorization for skin substitute applications. The documentation package typically includes wound measurements over four or more weeks showing failure to progress, photographic evidence, documentation of failed conservative therapy, and medical necessity language aligned with LCD criteria. Some MA plans require PA for each application in a treatment series, not just the initial one -- which means your PA workflow needs to handle rolling reauthorizations, not one-time approvals.

The skin substitute PA process is detailed in the skin substitute billing guide, but the key MA-specific point is this: do not assume that meeting Medicare FFS LCD criteria is sufficient for MA plan approval. MA plans can impose additional requirements beyond the LCD, and many do.

NPWT (Negative Pressure Wound Therapy)

Most MA plans require PA for NPWT, including both the initial placement and, in some cases, continuation beyond an initial authorization period (typically 30 days). The documentation bar includes wound type, wound size, wound bed condition, prior debridement, and a clear statement of why NPWT is medically necessary over conventional moist wound therapy. For coding and billing specifics, see the NPWT billing guide.

HBOT (Hyperbaric Oxygen Therapy)

HBOT requires prior authorization from essentially every payer, MA or otherwise. The PA threshold is high: qualifying diagnosis (typically Wagner Grade III or higher diabetic foot ulcers), documented failure of standard wound care over 30 or more days, adequate vascular status, and evidence of patient compliance with offloading and glycemic control.

E/M Visits and Debridement

Standard E/M visits and most debridement codes do not require PA under most MA plans. However, some plans are beginning to require PA for selective debridement (CPT 97597/97598) when performed at high frequency. If you treat chronic wounds weekly and debriding at most visits, check your MA plan contracts for frequency limits.

Reimbursement Differences: Expect 5-15% Below FFS

MA plans do not reimburse at the Medicare Fee Schedule rate. They negotiate contracted rates with each provider, and those rates are typically 5% to 15% below the Medicare FFS fee schedule for wound care services. For high-cost services like skin substitute applications, the discount can be steeper.

What this means in practice:

An E/M visit (99213) that pays roughly $92 under Medicare FFS might pay $80-$87 under your MA contract.
A debridement (97597) that pays approximately $120 under FFS might reimburse at $102-$114 under MA.
A skin substitute application (15271) plus the product Q-code can see a combined discount of 10-20% depending on the plan's product coverage and contracted rates.

These discounts compound across volume. A practice seeing 100 MA patients per week at an average 10% discount is leaving meaningful revenue on the table compared to FFS -- but the alternative is not seeing those patients, which is not realistic when MA represents the majority of your Medicare population.

Negotiating Better Rates

MA contract rates are negotiable. Your leverage comes from geographic exclusivity (few wound care providers in the service area), quality metrics (low readmission rates, high wound closure rates that boost the plan's Star Ratings), and network adequacy requirements (the plan cannot drop you without creating a coverage gap). Do not accept the initial offered rate as final. Counter with data.

Plan-Specific LCD Variations

MA plans are required to cover the same services as original Medicare, but they are not required to follow the same LCD criteria when making prior authorization decisions. Many contract with third-party utilization review organizations (eviCore, Carelon) that apply proprietary clinical criteria.

In practice: one MA plan may require 30 days of conservative therapy before approving a skin substitute, while another in the same market requires 60 days. One plan's reviewer may accept digital wound measurements; another requires narrative documentation by the treating clinician. One plan covers a specific skin substitute product at a negotiated rate; another does not cover that product at all and requires formulary substitution.

There is no shortcut around this variation. Your billing team needs plan-specific documentation of PA requirements, coverage criteria, and preferred products for every MA plan you contract with. Build this into your payer enrollment workflow from day one -- do not wait until the first denial to learn what a plan actually requires.

Common MA Denial Patterns in Wound Care

MA denials in wound care cluster around predictable patterns. Knowing these patterns lets you prevent the majority of them at the point of documentation, not after the claim is submitted.

Prior authorization not obtained. The most common MA denial -- the treatment was clinically appropriate, but no PA was on file. A workflow failure, not a clinical one. Verify PA requirements before every advanced treatment, every time.

Insufficient conservative therapy documentation. The submission did not demonstrate adequate failed conservative therapy. MA plans want specific treatments tried, with dates, durations, and documented outcomes. "Failed conservative therapy" as a checkbox does not satisfy the requirement.

Wound measurement gaps. Measurements missing for one or more visits in the treatment series. MA reviewers assess healing trajectory -- gaps make medical necessity determination impossible. Every visit needs measurements in centimeters with area calculated.

Product not covered under plan formulary. You applied a skin substitute not on the MA plan's covered product list. This denial never gets overturned on appeal -- the product is simply not a covered benefit. Check product coverage before applying a graft, not after.

Frequency limits exceeded. The plan limits treatment frequency (debridement intervals, skin substitute application caps per wound) and the claims exceeded those limits.

Timely filing exceeded. MA plans have their own filing limits, often shorter than Medicare FFS -- most require claims within 90 to 180 days, some within 60. Miss the window and the denial is not appealable.

Checking Coverage Before Treating

For MA patients, real-time eligibility verification is not optional -- it is a revenue protection requirement. Before scheduling any advanced wound care treatment for an MA patient, your front office or billing team should verify:

Active coverage -- Is the patient's MA plan still active? Has the plan changed since the last visit?
Network status -- Is your practice in-network with this specific MA plan?
PA requirements -- Does this treatment require prior authorization under this plan?
Product coverage -- If you plan to apply a skin substitute, is your intended product covered under this plan's formulary?
Remaining benefits -- Has the patient reached any frequency limits or benefit caps?

Running these checks manually across multiple MA plans is time-consuming but necessary. Medipyxis surfaces real-time eligibility verification at the point of scheduling and documentation, so your team catches coverage gaps before treatment rather than discovering them on the remittance advice weeks later.

Contracting with MA Plans

Start with the MA plans that cover the largest share of your patient population. In most wound care markets, that means UnitedHealthcare Medicare Advantage, Humana, Aetna Medicare, and the dominant regional plan in your state. Check your patient mix data to determine which plans actually drive volume.

Beyond reimbursement rates, negotiate these terms:

PA requirements -- Some contracts allow reduced PA requirements for established wound care providers with demonstrated quality outcomes.
Timely filing limits -- Push for at least 120 days. Shorter limits create unnecessary denial risk.
Payment timelines -- MA plans are required to pay clean claims within 30 days in most states, but contract language that specifies payment timelines gives you leverage when payment is slow.
Appeals process -- Understand the appeals timeline and process before you need it.

Staying out-of-network with an MA plan is possible, but the economics rarely work. OON reimbursement is lower, balance billing restrictions limit what you can collect from the patient, and MA plans actively steer patients toward in-network providers. For most wound care practices, contracting in-network with the major MA plans is the pragmatic choice. The payer enrollment guide covers the credentialing sequence for getting into these networks.

The 54% Reality

More than half of Medicare beneficiaries are enrolled in MA plans, and that share is growing. CMS projections suggest MA penetration will continue increasing through the decade. For wound care practices, this means MA billing is not a side concern or a secondary payer strategy -- it is the primary payer reality for the majority of your Medicare patients.

Building your billing operations to handle MA requirements from day one -- PA workflows, plan-specific documentation, eligibility verification, contract management -- is not optional infrastructure. It is the foundation of getting paid for the care you deliver to the patients who walk through your door.

If you are building or scaling a wound care practice, start with the payer enrollment timeline to get your MA contracts in place, then build your documentation workflow around LCD compliance as the baseline that every payer -- FFS and MA alike -- requires.